Interleukin-6 (IL-6) shares several biologic properties with IL-I , including hematopoietin-I activity and stimulation of T cells. Because many of their biologic activities overlap, we developed and used a specific radioimmunoassay (RIA) for IL-6 t o compare production of this cytokine on a molar basis with that of IL-la, IL-IB, and tumor necrosis factor (TNF)a. The RIA correlated well with the hybridoma bioassay for IL-6 ( r = .87, P < .001). Freshly isolated human peripheral blood mononuclear cells (PBMC) cultured in the absence of stimuli did not produce IL-6 in most cases. Kinetics of secretion and cell-association of IL-6 were studied. In contrast to IL-la but similar t o TNF, IL-6 was almost entirely secreted into the extracellular fluid. Incubation with different stimuli (lipopolysaccharide [LPS], phytohemagglutinin [PHA], Staphylococcus epidermidis, or ILl a ) resulted in production of IL-6. However, on a molar NTERLEUKIN-6 (IL-6) is a polypeptide cytokine with I several biologic activities. Initially described as a factor derived from fibroblasts with antiviral activity,' it was later found to be identical to B-cell stimulating factor-2,' hybridoma growth f a~t o r ,~ and hepatocyte stimulating f a~t o r .~ IL-6 appears to be part of a network of monokines triggering immune responses. Some of its activities are shared with other cytokines. For example, IL-6 and IL-I both act as "hematopoietin-l.rr5,6 IL-6, IL-1, and tumor necrosis factor (TNF) each induce a different set of hepatic acute phase proteins.'.'' In addition, IL-6, IL-1, and T N F increase a,-acid glycoprotein and decrease albumin gene expression in a synergistic manner." IL-I and IL-6 act synergistically on lectin-activated T-cell proliferation; IL-1 induces IL-6 in thymocytes and increases their responsiveness to IL-6.'2-'4 Both IL-I and IL-6 enhance synthesis of immunoglobulins by B but promote B-cell growth only when used together." Like IL-I and TNF, IL-6 also produces fever in rabbits."
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In view of the overlapping biologic effects of these cytokines and their simultaneous production by peripheral blood mononuclear cells (PBMC) in some pathologic states, it becomes increasingly important to specifically determine their concentrations in vitro and in vivo. Bioassays for IL-6 basis PBMC produced approximately two t o three times less IL-6 than IL-la, IL-I@, or TNF, regardless of the stimulus. The amount of IL-6 produced from PBMC was consistent when measured in the same subjects six times during a 12-week period. In a cohort of 38 donors, the coefficient of variation for IL-6 production was .32, compared with .92 for IL-lB and .96 for TNF. Comparing cytokine production by PBMC, there was a significant correlation between IL-6 and IL-16 ( r = .72) and between IL-6 and TNF ( r = .66). IL-6 did not stimulate IL-lB or TNF production, but suppressed IL-I 6 and TNF production induced by LPS or PHA by 30% (P < .01). This suppression of IL-16 and TNF by IL-6 appears t o be on the level of transcription.
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using hybridoma cell lines detect IL-6 at a concentration of 5 to 100 pg/mL.16 However, although not responding to other known cytokines, these assays could be influenced by combinations of cytokines and/or inhibitory substances present in human body fluids or produced from cultured cells. Moreover, some pharmacologic agents possibly present in samples from patients might also influence the bioassay." Since these agents are often protein-bound, as is IL-6 in human plasma," it is difficult to separate them from IL-6.
We describe the development and use of a specific radioimmunoassay (RIA) for IL-6 that reliably detects IL-6 at concentrations of less than 100 pg/mL. IL-6 production by human PBMC induced by a variety of stimuli was compared with IL-Ib, IL-la, and T N F produced in the same culture. We investigated the inter-and intrasubject variability of IL-6 production from PBMC, kinetics of secreted and cell-associated IL-6 after stimulation, and effect of IL-6 on production of IL-lfl and TNF.
MATERIALS AND METHODS

Materials.
New Zealand white rabbits were immunized with 100 pg of CHO-cell derived recombinant human (rh) IL-6 in complete Freund's adjuvant by intradermal injections. At monthly intervals, the rabbits received intramuscular injections of 25 pg IL-6 in incomplete Freund's adjuvant. After the third and fourth booster injections, the rabbits were bled and the whole serum was used as anti-IL-6 antiserum. IL-6 used for these studies was expressed in CHO cells as previously described6; a preparation expressed in Escherichia coli was purchased from Genzyme Inc, Boston, MA. IL-10 and IL-la were preparations previously described." rhIL-6 derived from CHO cells was labeled with '*'I using the chloramine-T method. Test samples and standards of IL-6 (10 ng/mL to 20 pg/mL) were assayed in duplicate in polystyrene tubes (75 x 11 mm; Stockwell Scientific, Walnut, CA). All dilutions of antibody, standards, and samples during the RIA were made in an RIA buffer (0.01 mol/L phosphate buffered saline [PBS], 0.25% bovine serum albumin [BSA; Pentax Fraction-V, Sigma, St Louis, MO] and 0.05% sodium azide). One hundred microliters of either standard or test sample were incubated at room temperature (RT) for 24 hours, with 100 pL of anti-IL-6 antiserum at a 1:4,000 dilution and 300 WL of a 1:600 dilution of normal rabbit
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INTERACTIONS IN IL-6, IL-1, AND TNF PRODUCTION 41 serum. On day two, 100 pL of IZ5I IL-6 containing 10,000 cpm were added. On day three, antigen-antibody complexes were precipitated by adding 500 gL of 6% polyethylene glycol (PEG) (molecular weight [mol wt] 8,000) and 2% sheep anti-rabbit immunoglobulin (Ig; Cambridge Medical Technology, Billerica, MA) in RIA buffer. After centrifugation at 1,000 x g for 30 minutes at 22OC, supernatants were decanted and pellets counted in a gamma counter. Counts were expressed as percent bound compared with tubes containing no IL-6 (Bo or zero standard). Percentages were transformed into a logit scale and plotted against a logarithmic scale of the IL-6 concentration.
Human blood was drawn in heparinized (10 U/mL) syringes and PBMC were separated by centrifugation over Ficoll/Hypaque (Ficoll Type 400, Sigma; Hypaque-M, 90%, Winthrop Breon Lab, New York, NY), prepared in ultrafiltered water. Cells were washed with normal saline and resuspended in RPMI 1640 culture medium (Whittaker M.A., Walkersville, MD), supplemented with 2 mmol/L L-glutamine, 100 U/mL penicillin, and 100 pg/mL streptomycin. RPMI was ultrafiltered (F40; Fresenius AG, Bad Homburg, FRG) to remove lipopolysaccharide (LPS).20 PBMC were counted using a Coulter counter (Coulter Electronics, Hialeah, FL), resuspended at 5 x lo6 cells/mL with 2% heatinactivated AB serum, and 100 pL/well were added to 96-well flat-bottom microtiter plates. PBMC were incubated in triplicate with an equal volume (100 pL) of either RPMI or a stimulus diluted in RPMI. Cells were stimulated with either IL-la at 100 ng/mL, LPS (LPS E coli 055:B5, Sigma) at 1 and 10 ng/mL; phytohemagglutinin (PHA-P; Difco, Detroit, MI, or Burroughs Wellcome, Research Triangle Park, NC) at 30 pg/mL; or heat-killed, opsonized (with 2.5% fresh autologous serum) Staphylococcus epidermidis at 20 bacteria per cell. After incubation for 18 hours at 37OC in 5% C02, plates were subjected to three freeze-thaw cycles to lyse the cells.*' IL-6, IL-1fl,22 IL-la," and TNFz4 were then measured in the total cell lysates containing both secreted and cell-associated cytokines by specific RIA. For all cytokines, unstimulated PBMC samples were measured undiluted; stimulated PBMC samples were diluted until their cytokine content was in the sensitive segment (40% to 70% binding) of the standard curve. For experiments comparing the production of different cytokines, cytokine levels were expressed on a molar basis, assuming a molecular mass of 26 Kd for IL-6 and 17 Kd for the other cytokines. All data are expressed as pmol/2.5 x IO6 PBMC.
Bioassay for IL-6. Biologic activity for IL-6 was determined using the IL-6 dependent cell line B9 as described Five thousand cells in 100 pL RPMI containing 5% fetal calf serum (FCS) (Hyclone, Logan, UT) were incubated in triplicate with 100 pL of four serial dilutions of the sample. After 72 hours, cells were labeled with 0.5 pCi of 'H-thymidine (New England Nuclear, Boston, MA). Four hours later, cells were harvested and the incorporated radioactivity was determined. In all assays a titration of rIL-6 was included as a standard. One unit was defined as the concentration of IL-6 giving half-maximal stimulation and varied from 0.3 to 1.4 pg/mL. Anti-IL-6 antiserum used for RIA completely blocked the IL-6-induced proliferation of the cell line.
PBMC were suspended in RPMI in 50 mL polypropylene tubes, and IL-6 was added. After incubation for 30 minutes at 37OC, stimuli were added and incubated for 4 more hours. Cells were pelleted at 500 x g and lysed in 4 mol/L guanidine i~othiocyanate.~~ Total cellular RNA was obtained by centrifugation through 5.7 M cesium chloride, 0.1 M EDTA. Equal amounts of RNA (20 pg unless otherwise indicated) were subjected to gel electrophoresis using 1.2% agarose containing 6.6% formaldehyde (Sigma). RNA was transferred to nylon membranes (Hybond-N; Amersham, Arlington Heights, IL) and fixed by shortwave ultraviolet (UV) radiation. Prehybridization, hybridization, and autoradiogPreparation ofPBMC. mRNA studies.
raphy were performed using standard technique^.^' The IL-1j3 probe was a 1,075 base pair (bp) fragment (bp position 279 to 1,354) of a full-length cDNA clone of the IL-I@ precursor subcloned in pGEM2. The TNFa probe was a 473-bp fragment of the full-length cDNA. DNA was labeled with "P-dCTP using a random primer DNA labeling kit (Boehringer Mannheim, Indianapolis, IN) to specific activities z io9 cpmlpg.
Statistical analysis. Results are expressed as mean r SEM unless otherwise indicated. Equations for the standard curves were calculated using a software program (Cricket Software, Malvern, PA). Results were compared using either Student's t test for paired samples or the Wilcoxon signed rank sum test. Analysis of variance for regression analysis was performed using Statview (Brainpower, Calabasas, CA), and significance was determined by the F test.
RESULTS
Comparison of RIA and B9 bioassay. The lower limit of IL-6 detection was defined at the 95% binding level. In over 50 RIAs, this ranged from 27 to 150 pg/mL; the average sensitivity was 100 pg/mL (1.03 to 5.76 pmol/mL, average 3.84 pmol/mL). The RIA did not detect 100 ng/mL of either IL-la, IL-lD, TNFa, TNFB, granulocyte-macrophage colony-stimulating factor (GM-CSF), or 1,000 U/mL IL-2.
The integrity of the '251-labeled protein was confirmed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). Diluting the standards in human plasma or urine from healthy donors had no influence on the standard curve (data not shown). We detected IL-6 in 50% of 17 plasmas and urines from healthy subjects averaging 187 34 pg/mL.26 There was a significant correlation (r = 37; P < .001) between the results of the RIA and the bioassay for IL-6 production by PBMC from 50 human subjects (Fig 1) . Different procedures were tested for optimal recovery of cytokines from cell cultures. PBMC from six donors were stimulated with 30 wg/mL phytohemagglutinin (PHA) (Difco, Detroit, MI) for 20 hours, and the culture plate was frozen. After thawing, PBMC from several wells from each donor were pooled and transferred to Eppendorf tubes in 1 mL aliquots. One sample was frozen and thawed two more times (F/T). CHAPS (Sigma) or SDS were added to the other aliquots to a final concentration of 9 mmol/L and O.l%, respectively. Samples were mixed, placed on ice for 60 minutes, and subjected to RIA. Addition of CHAPS inhibited the precipitation of the antigen-antibody complexes, causing a shift of the standard curve to indicate higher levels. Therefore, each RIA was performed with standards assayed under identical bulTer/detergent conditions as the test samples. Recovery of cytokines after freeze-thawing the cells from the six donors was set at 100% (Fig 2) . No significant effect between the amount of IL-6 recovered by freeze-thawing and extraction with CHAPS was observed. Similar results were seen for TNF, whereas extraction with CHAPS led to lower recovery Kinetics of cytokine production. For determination of secreted and cell-associated cytokines, PBMC in RPMl with 1% AB serum were incubated with LPS (100 ng/mL final concentration) in a 24-well tissue culture plate at 37OC. After different time points, the supernatant was removed, 1 mL of cold RPMl containing 1% AB serum was added to the well, and the adherent cells were scraped off. Supernatants and cell lysates were subjected to three freeze-thaw cycles and assayed in the respective RIAs. Figure 3 depicts the time course of cell-associated and secreted IL-6. IL-la, IL-I@, and T N F by PBMC of three donors after stimulation with 100 ng/mL LPS. IL-6 was detectable as early as 2 hours after stimulation and was found mainly in the supernatant; only a small amount was detected in the lysates. A similar pattern was observed for IL-IP and TNF. In contrast, IL-la levels were found mostly in cell lysates over the entire 48-hour period studied. All cytokines reached their maximal levels at 20 to 24 hours and decreased gradually thereafter. in a single RIA. There was variability in the amount of IL-6 produced by the same individual on different days. However, when IL-la, lL-l& and T N F were measured in the same samples, the intrasubject variability for IL-6 production was less than that of the other cytokines. This is illustrated by the standard deviations shown in Fig 4. The average coefficient of variation (SD/mean) in these four donors during the six time intervals was .21 for IL-6, .35 for IL-ID, .45 for IL-la, and .34 for TNF.
Recovery
Comparison of intersubject production of IL-6, IL-I, and TNF. We initially studied the spontaneous production of IL-6 in a cohort of 34 human donors. IL-6 production by unstimulated cells was found in IO cases, averaging 9.15 pmol (range 3.2 to 19.7 pmol). When PBMC of seven healthy donors were stimulated with 40 ng/mL IL-la (Fig   IL-6 8o 1
5), IL-6 and IL-ID production increased in every case
(P c .01, Wilcoxon test), whereas T N F was produced in 4 of 7 donors (P < .OS, Wilcoxon test).
PBMC of a cohort of 21 donors were stimulated with PHA (30 pg/mL, Wellcome), and the amount of IL-6, IL-IP and T N F were determined by the respective RIA. Similar to the intrasubject variability for the previous four donors (Fig 4) . 1L-6 production also showed the least variability. Mean cytokine production was 527 e 91 pmol for IL-lB, 281 e 35 for TNF, and 283 5 17 for IL-6. Coefficients of variation were .28 for IL-6, .88 for IL-ID, and .56 for TNF. We found a positive correlation between IL-lD and IL-6 ( r = .702, P c .OOOl). 
TNF
were stimulated with PHA (30 pg/mL) from a different source (Difco) than in the previous cohort. Again, IL-6 production among the donors was the least variable when compared with the other cytokines. Coefficient of variation was .37 for IL-6, .92 for IL-ID, and .96 for TNF. Figure 7 shows the regression analysis performed for the PBMC samples from these 38 donors stimulated with PHA. As in the study of 21 donors described above, the best correlation was found between IL-6 and IL-ID (r = .72, P < .0001);
correlation between IL-6 and TNF was less but still significant (r = .66, P < .001). 
E-6
Eflect of IL-6 on IL-IP and TNFproduction. IL-6 from 0.1 to 100 ng/mL did not stimulate IL-1P or T N F production (Fig 8) . When PBMC from seven different donors were preincubated with IL-6 for 30 minutes and subsequently stimulated with LPS (Fig 8A) or PHA (Fig 8B) , there was suppression of the production of IL-lP and TNF. This effect of IL-6 was observed at 0.1 ng/mL but was maximal at 100 ng/mL. IL-6 at 100 ng/mL decreased LPS-induced IL-lD by 32% and LPS-induced T N F by 33%; PHA-induced IL-lP was reduced by 27% and PHA-induced TNF by 32% (all P < .01, Student's paired t test). This effect of IL-6 could also be observed at the level of messenger RNA (mRNA) for IL-ID and TNF (Fig 9) ; thus, IL-6 decreased transcriptional activation of IL-1P and T N F in response to LPS or PHA.
DISCUSSION
We developed a specific RIA for determination of IL-6 levels produced from human PBMC. It forms the basis for unambiguous measurements of IL-6 from cell cultures and in biologic fluids. Moreover, the RIA allows comparison between production of different cytokines on a defined weight basis.
We found a good correlation (r = 3 7 ) between the results of RIA and bioassay determination of IL-6 in either PHA or IL-la-stimulated PBMC (Fig 1) . The bioassay resulted in 10-to 100-fold higher levels than the RIA using the same recombinant IL-6 preparation as standards in both assays. The reason for this discrepancy remains unknown. IL-6 is secreted from cells in at least five different mol wt forms probably due to different forms of glyc~sylation.~' Although the antibody used in the present study for the RIA detects all of them as confirmed by immunoprecipitation (data not shown), the different glycosylated forms of IL-6 may have different specific activities in the bioassay. Alternatively, the bioassay might be influenced by additional factors such as not-yet-identified cytokines or other substances that act synergistically with IL-6.
Spontaneous production of IL-6 by human PBMC in culture has been reported. '6,28 Elimination of possible sources of stimuli in our culture system (preparation of Ficoll/ Hypaque in ultrafiltered water, use of ultrafiltration to remove LPS and other sources of microbial contaminants from the tissue culture medium, and use of human AB serum instead of FCS) allowed us to culture PBMC with low spontaneous production of IL-6. We detected small amounts in only I O of 34 cases. Comparing the amount of total IL-6 produced after different stimuli (Figs 3 to 6) , it is clear that PHA and S epidermidis appear to induce more IL-6 from PBMC than LPS. Higher concentrations of LPS up to I O pg/mL did not stimulate more than 5 ng/mL in two donors studied (data not shown). In contrast to fibroblasts' and endothelial cells,29 the weakest stimulus for IL-6 production from PBMC is IL-la, as it is for IL-I@ and T N F production. This may reflect the low receptor densities for these two cytokines on PBMC.
We compared different procedures to optimize recovery of cytokines from PBMC cultures. Biologically active IL-1 has been shown to be released from cell membranes by trypsin'' or CHAPS detergent." We reported recently" that treatment with CHAPS actually decreased the recovery of immunoreactive IL-I? compared with freeze-thawing the cells, a finding confirmed in the present study. Exposure of the cells to CHAPS resulted in small increases in immunoreactivity for IL-la. IL-6, and T N F (Fig 2) ; however, the difference between freeze-thawing the cells and extraction with CHAPS was statistically significant only for IL-la.
Based on these findings, we investigated the kinetics of secretion of cytokines from PBMC after LPS stimulation.
We confirmed previous observations'*,." that IL-la remains primarily cell-associated, while IL-I? is secreted mainly into the supernatant. Most IL-6 was found in the extracellular fluid, whereas between 5% and 15% remained in the intracellular compartment. Similar to TNF," production and transport of IL-6 into the extracellular fluid seems closely coupled. This finding is not surprising because both IL-6 and T N F possess hydrophobic regions in their precursor amino acid sequence that are most likely signal peptide^.'^ However, the patterns of secretion of IL-6 might be different in other cell types. Although fibroblasts secrete IL-6, to our knowledge there have been no studies comparing intra-and extracellular localization of IL-6. IL-l is found in the intracellular compartment of fibroblasts.'5 B cells,'6 and T cells," but is not secreted from these cells. A similar behavior could be true for IL-6.
Similar to other cytokines, there was a considerable intraand intersubject variability for the production of IL-6 from PBMC. Interestingly. the variation in IL-6 production was less than that for IL-I? and TNF. using different stimuli in three separate studies of cohorts using PBMC from 62 human subjects. For IL-I?, high and low "producers" have been described.'' IL-6 appears to be produced more consistently in the donors studied in this report. This could reflect an efficient control of 1L-6 gene expression in PBMC.
Regression analysis with samples from 38 different donors showed a significant correlation between IL-6 and IL-I? (r = .72, P < .OOl) and a weaker, but significant correlation between IL-6 and T N F (r = .66, P < .OOl). It is unknown whether the production of these cytokines is directly linked or whether this correlation exists because IL-l and T N F induce IL-6. However, the concentrations of IL-6 we measured in IL-la-stimulated PBMC were low compared with theamount induced by PHA, indicating that PHA directly stimulated IL-6 rather than solely via production of IL-l or TNF.
Unlike IL-I? and TNF, two cytokines known to stimulate each others' production in vitro and in vivo, IL-6 did not stimulate IL-1 or TNF. In contrast, IL-6 had a suppressive effect on production of IL-10 and TNF induced by LPS or PHA (Fig 8) . This suppression was also observed on the level of transcription. Therefore, IL-6 may provide a negative feedback signal in the self-augmenting network of CYtokines? as is IFN-7, a cytokine known to suppress IL-l-induced IL-1 . 38 The suppressive effect of IL-6 on IL-1 and TNF might be particularly important in cell types that express largeamounts of IL-6 in response to IL-1, such as fibroblasts3 and endothelial cellsz9
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